Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Revenue

In the year 2023, Fulgent Genetics had annual revenue of $289.21M, a decrease of -53.27%. Revenue in the quarter ending December 31, 2023 was $70.51M with 4.14% year-over-year growth.

• Revenue (ttm): $289.21M
• Revenue Growth: -53.27%
• P/S Ratio: 2.13
• Revenue / Employee: $244,268
• Employees: 1,184
• Market Cap: 616.55M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	289.21M	-329.76M	-53.27%
Dec 31, 2022	618.97M	-373.62M	-37.64%
Dec 31, 2021	992.58M	570.87M	135.37%
Dec 31, 2020	421.71M	389.18M	1,196.46%
Dec 31, 2019	32.53M	11.18M	52.35%
Dec 31, 2018	21.35M	2.62M	13.99%
Dec 31, 2017	18.73M	454.00K	2.48%
Dec 31, 2016	18.28M	8.70M	90.85%
Dec 31, 2015	9.58M	8.30M	649.30%
Dec 31, 2014	1.28M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.